Effective Management with IMPELLA CP® and Hypothermia Therapy for a Case of Severe Ischemic Coronary Disease after Cardiopulmonary Arrest

Effective Management with IMPELLA CP ® and Hypothermia Therapy for a Case of Severe Ischemic Coronary Disease after Cardiopulmonary Arrest A 67-year-old man was admitted to our hospital following cardiopulmonary arrest （ CPA ） during work. After resuscitation, coronary angiography revealed left main coronary artery stenosis and three-vessel disease. We considered that coronary artery revascularization was required, but the neurological prognosis was unknown. Thus, an IMPELLA CP ® device was inserted and systemic management, including hypothermic therapy, was initiated. Circulatory conditions were stable during hypothermia therapy. Rewarming was initiated 24 h later, and we confirmed no abnormal neurological findings. Emergency off-pump coronary artery bypass was then performed. During the procedure, hemodynamic status was maintained using the IMPELLA CP ® device. After surgery, the patient was discharged without neurological complications. We report the management of a patient with severe three-vessel disease after resuscitation for CPA using an IMPELLA CP ® device and hypothermic therapy. Jpn. J. Cardiovasc. Surg. 50 : 256 - 260 （ 2021 ）

[1]  J. Henriques,et al.  Mechanical circulatory support in cardiogenic shock from acute myocardial infarction: Impella CP/5.0 versus ECMO , 2020, European heart journal. Acute cardiovascular care.

[2]  A. Zangrillo,et al.  The role of different mechanical circulatory support devices and their timing of implantation on myocardial damage and mid‐term recovery in acute myocardial infarction related cardiogenic shock , 2018, Journal of interventional cardiology.

[3]  R. Kato,et al.  Clinical Usefulness of Wearable Cardioverter Defibrillator (WCD) and Current Understanding of Its Clinical Indication in Japan. , 2018, Circulation journal : official journal of the Japanese Circulation Society.

[4]  M. Monaco,et al.  Successful use of the Impella Recover LP 5.0 device for circulatory support during off-pump coronary artery bypass grafting , 2014, International journal of surgery case reports.

[5]  I. Palacios,et al.  A Prospective, Randomized Clinical Trial of Hemodynamic Support With Impella 2.5 Versus Intra-Aortic Balloon Pump in Patients Undergoing High-Risk Percutaneous Coronary Intervention: The PROTECT II Study , 2012, Circulation.

[6]  Alan D. Lopez,et al.  Mild therapeutic hypothermia to improve the neurologic outcome after cardiac arrest. , 2002, The New England journal of medicine.

[7]  Karen Smith,et al.  Treatment of Comatose Survivors of Out-of-hospital Cardiac Arrest With Induced Hypothermia , 2003 .

[8]  Fumiaki Nagashima,et al.  Cerebral Protection in Neuroanesthesia and Neurointensive Care , 2017 .

[9]  E. Navarese,et al.  Off-pump coronary artery bypass grafting improves short-term outcomes in high-risk patients compared with on-pump coronary artery bypass grafting: Meta-analysis. , 2016, The Journal of thoracic and cardiovascular surgery.

[10]  T. Tobaru.  Revascularization in cardiogenic shock and severe CHF complicating acute myocardial infarction , 2016 .

[11]  A. Spotnitz,et al.  The Impella device for acute mechanical circulatory support in patients in cardiogenic shock. , 2014, The Annals of thoracic surgery.